The CoREST complex inhibitor, corin, leads to decreased tumor growth, increased cellular differentiation and extended lifespan in atypical teratoid rhabdoid tumor xenograft models
Anupa Geethadevi(Bloomberg (United States)), Rhoda M. Alani(Boston University), Robert Fisher(Boston University), Philip A. Cole(Brigham and Women's Hospital), Charles G. Eberhart(Johns Hopkins University), Marianne Collard(Boston University), Eric H. Raabe(Johns Hopkins University), Jeffrey Rubens(Johns Hopkins University), Vikas Kumar(Chinese Academy of Sciences), Samuel J. Beck(Boston University), Jinchong Xu(Johns Hopkins University), Yiming Deng(Capital Medical University), Nikhil Vaidya(Boston University), Khoa Pham(Johns Hopkins University), Tyler Findlay(Johns Hopkins University), Calixto‐Hope G. Lucas(Johns Hopkins University)
Cited by 1
Related Papers
Detection of Circulating Tumor DNA in Early- and Late-Stage Human Malignancies
|Science Translational Medicine|2014|5.1k
An Allosteric Mechanism for Activation of the Kinase Domain of Epidermal Growth Factor Receptor
|Cell|2006|1.6k
Medulloblastoma Comprises Four Distinct Molecular Variants
|Journal of Clinical Oncology|2010|1.4k
Intertumoral Heterogeneity within Medulloblastoma Subgroups
|Cancer Cell|2017|1.3k
Altered Telomeres in Tumors with <i>ATRX</i> and <i>DAXX</i> Mutations
|Science|2011|1.1k